New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
LIFE

Evolve Global Healthcare Enhanced Yield ETF

The LIFE Exchange Traded Fund (ETF) is provided by Evolve ETFs. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$17.90
+$0.12 (+0.67%) yesterday
1:30 PM 07/27/26 Closed
1D price range
$17.85$18.03
52W price range
$16.48$20.14
YTD Perf.
-1.05%
YTD Flows
Annualized volatility
Fund AuM
€203M
Share class AuM
€167M
TTM Yield
Tracking Error
Tracking Difference
ISIN
CA30051T1012
TER
0.65%
Inception date
10/25/2017
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 27, 2026
-10%-5%0%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 06/30/26
Healthcare
101.40%
Latest LIFE news

No content available for this fund

FAQ about LIFE

LIFE is a Active ETF. This ETF provides exposure to Large Cap Developed markets Health Care Equities.
LIFE carries a total expense ratio (TER) of 0.65%, indicating the annual cost for holding the fund.
LIFE was introduced to the market on October 25, 2017. It trades on Canada
Evolve Global Healthcare Enhanced Yield ETF, LIFE, is provided by Evolve ETFs. Learn more about Evolve ETFs here.
LIFE oversees €167M in assets as of July 27, 2026.
LIFE follows a distributing dividend policy, meaning it pays out income to investors. As of July 27, 2026, its 12-month trailing yield was 11.67%.
As of June 30, 2026, LIFE has significant geographic allocations in USA, Switzerland and United Kingdom.
As of June 30, 2026, LIFE focuses largely on Healthcare.
As of June 30, 2026, LIFE holds 20 positions in its portfolio, with 78.83% of assets concentrated in its top 15 holdings.
As of June 30, 2026, LIFE top three holdings include Novo Nordisk A/S, Eli Lilly & Co. and AbbVie, Inc..
The base currency of LIFE is CAD.
LIFE is hedged, meaning it seeks to minimize the impact of currency fluctuations between its base currency and the currency of the underlying assets.
Data as of 06/30/26
Novo Nordisk A/S
6.45%
Eli Lilly & Co.
6.41%
AbbVie, Inc.
6.18%
Johnson & Johnson
5.44%
Merck & Co., Inc.
5.29%
Amgen, Inc.
5.19%
Novartis AG
5.11%
Roche Holding AG
5.11%
Danaher Corp.
5.10%
Thermo Fisher Scientific, Inc.
5.07%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight